ReShape Lifesciences Inc
NASDAQ:RSLS
ReShape Lifesciences Inc
NASDAQ:RSLS
Price:
3.92
USD
22.5%
Market Cap:
$290.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
US |
|
Foresta Group Holdings Ltd
ASX:FGH
|
AU |
|
G
|
Grupo Ecoener SA
MAD:ENER
|
ES |
|
K
|
Korea Computer Terminal Inc
KOSDAQ:089150
|
KR |
|
S
|
SM Life Design Group Co Ltd
KOSDAQ:063440
|
KR |
|
NN Group NV
AEX:NN
|
NL |
|
P
|
Phuong Nam Education Investment and Development JSC
VN:SED
|
VN |
|
S
|
Song Da 4 JSC
VN:SD4
|
VN |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RSLS's stock price target?
Not Available
RSLS doesn't have any price targets made by Wall Street professionals.
What is ReShape Lifesciences Inc's Revenue forecast?
Projected CAGR
53%
53%
For the last 9 years the
compound annual growth rate for
ReShape Lifesciences Inc's revenue is
8%.
The projected
CAGR
for the next 1 year is
53%.
